GLUE · Monte Rosa Therapeutics, Inc.
$15.50
-0.34 (-2.15%)
At close · Aug 14
Market Cap
$1.32B
Shares
85.31M
Monte Rosa Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Monte Rosa Therapeutics, Inc. (GLUE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY24 · Q4
2025-03-20
Monte Rosa Therapeutics, Inc. Q4 FY2024 Earnings Call
Confident tone
MRT-6160 / VAV1 Phase 1 results
NEK7 program
Pipeline breadth in I&I
Revenue
$60.65M*
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Monte Rosa Therapeutics, Inc. Q3 FY2024 Earnings Call
Revenue
$9.22M
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-14
Monte Rosa Therapeutics, Inc. Q4 FY2023 Earnings Call
Revenue
$*
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q4
2023-03-16
Monte Rosa Therapeutics, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–4 of 4 earnings calls
Key facts
CIK
1826457
CUSIP
61225M102
13F (30d)
188 filings
184 filers
Visit website
Investor relations